Sphere Fluidics Granted US Patent on Picodroplet Separation

Sphere Fluidics has been awarded a US patent on separation of picodroplets using novel microfluidic designs. “This brings our patent portfolio to 52 patents with 11 families and 22 granted international patents” said Dr Marian Rehak (Director of R&D). “Our patent portfolio and associated Freedom-To-Operate is an amazing asset” said Dr Rob Marchmont (Commercial Director). “This patent collection underpins development and protects our new Cyto-Mine single cell analysis platform and our other emerging mass spectrometry platform (ESI-Mine). It is also available for licensing to approved external organisations”.